Portnoy Law Firm Announces Class Action on Behalf of Inspire Medical Investors

Core Viewpoint - Inspire Medical is facing a class action lawsuit due to alleged misleading statements regarding the launch of its Inspire V product, which reportedly encountered significant challenges and poor demand [3][4]. Summary by Sections Class Action Details - The class action is on behalf of investors who purchased securities between August 6, 2024, and August 4, 2025, with a deadline of January 5, 2025, for filing a lead plaintiff motion [1]. - Investors are encouraged to contact the Portnoy Law Firm for legal rights discussions and case evaluations [2]. Allegations Against Inspire Medical - The lawsuit claims that Inspire Medical made false statements about the successful launch of Inspire V, which was actually hindered by poor demand and excess inventory at provider centers [3]. - It is alleged that many centers did not complete necessary training and onboarding, which delayed the launch and billing processes for Medicare patients [4]. Impact on Financial Guidance - Following the revelation of these issues on August 4, 2025, Inspire Medical reduced its 2025 earnings guidance by over 80%, leading to a more than 32% decline in its stock price [4].